Behavioral indicators of hallucinosis in levodopa-treated Parkinson's disease.
D006212:Hallucinations / Q000139:chemically induced*; D006801:Humans; D007980:Levodopa / Q000009:adverse effects* / Q000627:therapeutic use; D008950:MMPI; D008875:Middle Aged; D010300:Parkinson Disease / Q000188:drug therapy* / Q000523:psychology; D011594:Psychometrics; D012306:Risk
D007980:Levodopa